FIELD: medicine.
SUBSTANCE: present invention relates to a proprietary hepatitis C prodrug of formula 01 and a pharmaceutically acceptable salt thereof, a method for preparing it and a pharmaceutical composition based thereon. Compound 01 is obtained in accordance with scheme:
.
EFFECT: novel effective pro-drug prodrug and a pharmaceutical composition based on said prodrug, as well as an effective method for preparing said hepatitis C, are proposed.
4 cl, 11 ex, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PRODRUG BASED ON TENOFOVIR MONOBENZYL ESTER PHOSPHAMIDE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2016 |
|
RU2719594C2 |
| QUINOLINE COMPOUNDS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF AS MEDICINAL AGENT WHICH INHIBITS URATE TRANSPORTER | 2016 |
|
RU2715229C2 |
| FGFR INHIBITOR, METHOD FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2771526C1 |
| TRICYCLIC JANUS KINASE 1 INHIBITORS, COMPOSITIONS, METHODS OF PRODUCTION AND USE THEREOF | 2019 |
|
RU2824349C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF | 2012 |
|
RU2665571C2 |
| CHEMICAL COMPOUNDS FOR INHIBITING HCV, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | 2014 |
|
RU2671194C2 |
| FLUORO-SUBSTITUTED CYCLIC AMINO COMPOUNDS AND METHODS FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | 2013 |
|
RU2605931C2 |
| TRYPTOLIDE DERIVATIVE, METHOD FOR ITS PREPARATION AND APPLICATION | 2018 |
|
RU2753036C1 |
| BENZAMIDE DERIVATIVES HAVING ANTICANCER ACTIVITY, METHODS FOR PRODUCTION THEREOF AND USE THEREOF | 2011 |
|
RU2565079C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND USE THEREOF | 2014 |
|
RU2696585C2 |
